VanEck Vectors Morningstar Wide Moat ETF (MOAT)

53.70 +0.01  +0.02% NYSE Arca Nov 21, 16:59 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 53.67
Discount or Premium to NAV 0.04%
Turnover Ratio 56.00%
1 Year Fund Level Flows 832.65M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 6.40% 6.32% 4.33% 3
3M 11.90% 11.91% 7.89% 1
6M 15.44% 15.39% 9.17% 1
YTD 30.41% 30.46% 24.57% 3
1Y 23.18% 23.18% 14.31% 3
3Y 17.05% 17.02% 12.95% 2
5Y 12.54% 12.54% 9.18% 1
10Y -- -- 11.78% --
15Y -- -- 8.07% --
20Y -- -- 5.95% --
As of Nov. 20, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 100.0% 100.0% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 20, 2019

Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 20, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 2.22%
Communication Services 6.09%
Consumer Cyclical 10.83%
Consumer Defensive 8.71%
Energy 4.11%
Financial Services 14.48%
Healthcare 22.79%
Industrials 11.31%
Real Estate 0.00%
Technology 17.05%
Utilities 2.41%
As of Nov. 19, 2019

Stock Market Capitalization

Giant 36.16%
Large 44.71%
Medium 13.71%
Small 5.42%
Micro 0.00%
As of Nov. 19, 2019

Stock Style Exposure

Large Cap Value 27.74%
Large Cap Blend 35.54%
Large Cap Growth 17.59%
Mid Cap Value 3.96%
Mid Cap Blend 2.57%
Mid Cap Growth 7.18%
Small Cap Value 2.01%
Small Cap Blend 3.41%
Small Cap Growth 0.00%
As of Nov. 19, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
STT State Street Corporation 2.92% 73.01 +0.00%
BIIB Biogen Inc 2.77% 288.48 +1.08%
AMGN Amgen Inc 2.72% 228.93 +1.52%
INTC Intel Corp 2.68% 58.33 +0.74%
BMY Bristol-Myers Squibb Company 2.64% 56.60 +0.34%
UNH UnitedHealth Group Inc 2.61% 276.50 +0.34%
WFC Wells Fargo & Co 2.60% 53.56 +0.04%
GWRE Guidewire Software Inc 2.59% 118.63 -0.40%
EMR Emerson Electric Co 2.59% 73.59 +1.15%
ZBH Zimmer Biomet Holdings Inc 2.59% 142.28 -0.20%
As of Nov. 19, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar® Wide Moat Focus IndexSM. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is comprised of securities issued by companies that Morningstar, Inc. ("Morningstar") determines to have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors ("wide moat companies"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Blend
Prospectus Objective Growth
Fund Owner Firm Name VanEck
Benchmark Index
Morningstar Wide Moat Focus TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Guo Hua (Jason) Jin 1.75 yrs
Hao-Hung (Peter) Liao 7.53 yrs

Net Fund Flows

1M 143.07M
3M 206.43M
6M 285.93M
YTD 662.57M
1Y 832.65M
3Y 1.333B
5Y 1.147B
10Y --
As of Oct. 31, 2019

Risk Info

Beta (5Y) 1.121
Max Drawdown (All) 16.11%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 1.689
30-Day Rolling Volatility 9.76%
Daily Value at Risk (VaR) 1% (All) 2.42%
Monthly Value at Risk (VaR) 1% (All) 8.31%

Fundamentals

Dividend Yield TTM (11-21-19) 1.37%
30-Day SEC Yield (10-30-15) 1.62%
7-Day SEC Yield --
Weighted Average PE Ratio 20.61
Weighted Average Price to Sales Ratio 2.685
Weighted Average Price to Book Ratio 3.828
Weighted Median ROE 23.70%
Weighted Median ROA 8.52%
Forecasted Dividend Yield 2.21%
Forecasted PE Ratio 17.58
Forecasted Price to Sales Ratio 2.546
Forecasted Price to Book Ratio 3.638
Number of Holdings 52
As of Nov. 20, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 8.91%
Forecasted Book Value Growth 7.05%
Forecasted Cash Flow Growth 9.85%
Forecasted Earnings Growth 19.39%
Forecasted Revenue Growth 8.98%
As of Nov. 20, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 4/24/2012
Termination Date
Last Annual Report Date 9/30/2018
Last Prospectus Date 2/1/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.